Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer
Clinical trial NCT03300765 · UNKNOWN
Trial details
- NCT number
- NCT03300765
- Sponsor
- Xiayun He, MD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2019-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.